Response to antidepressants among patients with unipolar depression with and without comorbid epilepsy-a nation-wide population-based longitudinal study

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Response to antidepressants among patients with unipolar depression with and without comorbid epilepsy-a nation-wide population-based longitudinal study. / Kessing, Lars Vedel; Ziersen, Simon Christoffer; Budtz-Jørgensen, Esben; Gerds, Thomas.

In: Journal of Affective Disorders, Vol. 299, 15.02.2022, p. 1-5.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Kessing, LV, Ziersen, SC, Budtz-Jørgensen, E & Gerds, T 2022, 'Response to antidepressants among patients with unipolar depression with and without comorbid epilepsy-a nation-wide population-based longitudinal study', Journal of Affective Disorders, vol. 299, pp. 1-5. https://doi.org/10.1016/j.jad.2021.11.046

APA

Kessing, L. V., Ziersen, S. C., Budtz-Jørgensen, E., & Gerds, T. (2022). Response to antidepressants among patients with unipolar depression with and without comorbid epilepsy-a nation-wide population-based longitudinal study. Journal of Affective Disorders, 299, 1-5. https://doi.org/10.1016/j.jad.2021.11.046

Vancouver

Kessing LV, Ziersen SC, Budtz-Jørgensen E, Gerds T. Response to antidepressants among patients with unipolar depression with and without comorbid epilepsy-a nation-wide population-based longitudinal study. Journal of Affective Disorders. 2022 Feb 15;299:1-5. https://doi.org/10.1016/j.jad.2021.11.046

Author

Kessing, Lars Vedel ; Ziersen, Simon Christoffer ; Budtz-Jørgensen, Esben ; Gerds, Thomas. / Response to antidepressants among patients with unipolar depression with and without comorbid epilepsy-a nation-wide population-based longitudinal study. In: Journal of Affective Disorders. 2022 ; Vol. 299. pp. 1-5.

Bibtex

@article{8014b8ae301346d0a236e17e500ab029,
title = "Response to antidepressants among patients with unipolar depression with and without comorbid epilepsy-a nation-wide population-based longitudinal study",
abstract = "Objective: In a nation-wide population-based longitudinal register linkage study to investigate long-term response to antidepressants in patients with depression with and without comorbid epilepsy. Methods: We used Danish nation-wide population-based longitudinal register linkage to identify 1487 patients with depression and comorbid epilepsy and 71,163 patients with depression without comorbid epilepsy during a study period from 1995 to 2017. Response was defined as continuous monotherapy with an antidepressant drug without switch to or add-on of another antidepressant drug, an antipsychotic drug or lithium or hospitalization during an up to ten-year follow-up period. We calculated standardized absolute risks and differences thereof with respect to age, gender, socioeconomic status and comorbidity with other physical disorders than epilepsy. Results: In patients with depression, response to antidepressants was decreased with versus without comorbid epilepsy during the ten-year follow-up period. One year after start of antidepressant treatment the proportion of responders was 12% (CI: 10%-14%) lower in patients with versus without comorbid epilepsy in the standardized population. Response to antidepressants were specifically decreased among younger and unemployed patients with depression and comorbid epilepsy. Limitations: We did not include sub-analyses according to subtypes of epilepsy. Conclusions: Response to antidepressants was decreased in patients with comorbid epilepsy versus without comorbid epilepsy at all time points during a ten-year follow-up period. The study highlights the need for closely clinical monitoring and psychological support for patients with depression and comorbid epilepsy and emphasize the need for further long-term studies of effect of interventions.",
keywords = "Antidepressants, Comorbid, Depression, Epilepsy",
author = "Kessing, {Lars Vedel} and Ziersen, {Simon Christoffer} and Esben Budtz-J{\o}rgensen and Thomas Gerds",
note = "Publisher Copyright: {\textcopyright} 2021 Elsevier B.V.",
year = "2022",
month = feb,
day = "15",
doi = "10.1016/j.jad.2021.11.046",
language = "English",
volume = "299",
pages = "1--5",
journal = "Journal of Affective Disorders",
issn = "0165-0327",
publisher = "Elsevier",

}

RIS

TY - JOUR

T1 - Response to antidepressants among patients with unipolar depression with and without comorbid epilepsy-a nation-wide population-based longitudinal study

AU - Kessing, Lars Vedel

AU - Ziersen, Simon Christoffer

AU - Budtz-Jørgensen, Esben

AU - Gerds, Thomas

N1 - Publisher Copyright: © 2021 Elsevier B.V.

PY - 2022/2/15

Y1 - 2022/2/15

N2 - Objective: In a nation-wide population-based longitudinal register linkage study to investigate long-term response to antidepressants in patients with depression with and without comorbid epilepsy. Methods: We used Danish nation-wide population-based longitudinal register linkage to identify 1487 patients with depression and comorbid epilepsy and 71,163 patients with depression without comorbid epilepsy during a study period from 1995 to 2017. Response was defined as continuous monotherapy with an antidepressant drug without switch to or add-on of another antidepressant drug, an antipsychotic drug or lithium or hospitalization during an up to ten-year follow-up period. We calculated standardized absolute risks and differences thereof with respect to age, gender, socioeconomic status and comorbidity with other physical disorders than epilepsy. Results: In patients with depression, response to antidepressants was decreased with versus without comorbid epilepsy during the ten-year follow-up period. One year after start of antidepressant treatment the proportion of responders was 12% (CI: 10%-14%) lower in patients with versus without comorbid epilepsy in the standardized population. Response to antidepressants were specifically decreased among younger and unemployed patients with depression and comorbid epilepsy. Limitations: We did not include sub-analyses according to subtypes of epilepsy. Conclusions: Response to antidepressants was decreased in patients with comorbid epilepsy versus without comorbid epilepsy at all time points during a ten-year follow-up period. The study highlights the need for closely clinical monitoring and psychological support for patients with depression and comorbid epilepsy and emphasize the need for further long-term studies of effect of interventions.

AB - Objective: In a nation-wide population-based longitudinal register linkage study to investigate long-term response to antidepressants in patients with depression with and without comorbid epilepsy. Methods: We used Danish nation-wide population-based longitudinal register linkage to identify 1487 patients with depression and comorbid epilepsy and 71,163 patients with depression without comorbid epilepsy during a study period from 1995 to 2017. Response was defined as continuous monotherapy with an antidepressant drug without switch to or add-on of another antidepressant drug, an antipsychotic drug or lithium or hospitalization during an up to ten-year follow-up period. We calculated standardized absolute risks and differences thereof with respect to age, gender, socioeconomic status and comorbidity with other physical disorders than epilepsy. Results: In patients with depression, response to antidepressants was decreased with versus without comorbid epilepsy during the ten-year follow-up period. One year after start of antidepressant treatment the proportion of responders was 12% (CI: 10%-14%) lower in patients with versus without comorbid epilepsy in the standardized population. Response to antidepressants were specifically decreased among younger and unemployed patients with depression and comorbid epilepsy. Limitations: We did not include sub-analyses according to subtypes of epilepsy. Conclusions: Response to antidepressants was decreased in patients with comorbid epilepsy versus without comorbid epilepsy at all time points during a ten-year follow-up period. The study highlights the need for closely clinical monitoring and psychological support for patients with depression and comorbid epilepsy and emphasize the need for further long-term studies of effect of interventions.

KW - Antidepressants

KW - Comorbid

KW - Depression

KW - Epilepsy

U2 - 10.1016/j.jad.2021.11.046

DO - 10.1016/j.jad.2021.11.046

M3 - Journal article

C2 - 34822917

AN - SCOPUS:85119927946

VL - 299

SP - 1

EP - 5

JO - Journal of Affective Disorders

JF - Journal of Affective Disorders

SN - 0165-0327

ER -

ID: 289459860